Abundant Covid-19 Medication Stock Now Available in 10 Provinces

The Indonesian government continues to boost the availability of medicines supporting COVID-19 treatment to ensure affordability and accessibility across all regions. To ensure transparency, the Ministry of Health has partnered with all national pharmacies to collaboratively make their individual drug stock data publicly available.

As of this week, at least 11 pharmacies have joined, providing transparency on the stock of commonly used COVID-19 medications. These drugs include Azithromycin, Favipiravir, Immunoglobulin, Ivermectin, Oseltamivir, Remdesivir, and Tocilizumab. Currently, at least 6.5 million doses of these medications have been distributed throughout Indonesia.

The availability of these drugs has increased significantly compared to last week, when only Kimia Farma pioneered data on drug availability, with a figure less than half of today's release.

According to the Ministry of Health's data, currently only 10 provinces have drug stocks exceeding 100,000 units. These are predominantly located on Java Island. Provinces outside Java with abundant stock include Bali, Papua, South Sulawesi, and East Nusa Tenggara.

In terms of the number of participating pharmacies, West Java ranks first with 1,104 pharmacies, an increase from 723 last week. Drug availability in this region has also reached 1.4 million units, with stocks comprising 42,000 Azithromycin, 306,000 Favipiravir, 54,000 Ivermectin, 833,000 Multivitamins, and 149,000 Oseltamivir.

DKI Jakarta is second with 1,071 pharmacies. Drug stocks in the capital city are recorded at 1.1 million units. Various types of drugs are available, except for Immunoglobulin, Remdesivir, and Tocilizumab, which are out of stock.

Furthermore, four provinces have fewer than 10 pharmacies to serve the needs of an entire province. These regions are Bangka Belitung Islands, Bengkulu, Central Sulawesi, and West Sulawesi.